Fact CheckerSign in

NCT04913012Completed

Exercise Booster Sessions in People With Multiple Sclerosis

Sustainability of Exercise Therapy by the Use of Exercise Booster Sessions in People With Multiple Sclerosis.

Source: ClinicalTrials.gov · Last updated 27 Dec 2024

Brief summary (registry, in English)

This study wants to investigate whether exercise booster sessions applied in the follow-up period after an exercise intervention can increase the sustainability of exercise induced effects in persons with multiple sclerosis. The study will be a randomized, multi-site, controlled trial. Participants will from the beginning be allocated to either aerobic training group, resistance training group or control group. After a 12 week exercise intervention, the exercise groups will be additionally randomized to receive either exercise booster sessions + standard care or just standard care in the 40 week follow up period. It is hypothesized that exercise booster sessions can increase the sustainability of exercise induced effects.

Status (registry)
Completed
Study type
Interventional
Enrollment
150 (actual)
First submitted
26 May 2021
Start date
1 Aug 2021
Primary completion date
4 Oct 2024
Lead sponsor
University of Aarhus
NCT number
NCT04913012

What you commit to

  • Study type: Interventional
  • Participants enrolled: 150
  • From 1 Aug 2021 to the primary completion date, 4 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Comprise comorbidities (cardiovascular-, respiratory-, orthopedic- or other neurological diseases.)

Who the study is looking for

  • A definite diagnosis of MS, according to the McDonald criteria
  • Walking \<650m on 6MWT.
  • Exercising ≤ two sessions per week of moderate-to-high intensity during the past six months.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aarhus University
Coordinator of this site? Confirm its status
AarhusDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.